NASA's Mars Perseverance snaps a selfie as a Martian dust devil blows by
This image provided by NASA shows Perseverance taking a selfie on May 10, 2025. (NASA via AP)
CAPE CANAVERAL, Fla. — The latest selfie by NASA's Perseverance rover at Mars has captured an unexpected guest: a Martian dust devil.
Resembling a small pale puff, the twirling dust devil popped up 3 miles (5 kilometres) behind the rover during this month's photo shoot. Released Wednesday, the selfie is a composite of 59 images taken by the camera on the end of the rover's robotic arm, according to NASA.
It took an hour to perform all the arm movements necessary to gather the images, 'but it's worth it,' said Megan Wu, an imaging scientist from Malin Space Science Systems, which built the camera.
'Having the dust devil in the background makes it a classic,' Wu said in a statement.
The picture — which also shows the rover's latest sample borehole on the surface — marks 1,500 sols or Martian days for Perseverance. That's equivalent to 1,541 days on Earth.
Perseverance is covered with red dust, the result of drilling into dozens of rocks. Launched in 2020, it's collecting samples for eventual return to Earth from Jezero Crater, an ancient lakebed and river delta that could hold clues of any past microbial life.
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Marcia Dunn, The Associated Press
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Japan Forward
3 hours ago
- Japan Forward
Japan's ispace Eyes First Private Landing by Asian Firm
A second lunar lander developed by Japanese space startup ispace Inc. (based in Minato, Tokyo) is set to attempt a moon landing in the early hours of June 6 (Japan time). If successful, it would be the first lunar landing ever achieved by a private company in Asia. The mission also aims to collect samples of lunar soil (regolith) using a small rover and carry out the world's first commercial transaction on the Moon by transferring ownership of the collected material to NASA. Launched in January 2025 from Florida aboard a SpaceX rocket, the lander is currently orbiting the Moon at an altitude of approximately 100 kilometers, traveling at around 5,800 kilometers per hour in a circular path. At about 3:15 AM on June 6, the craft's main engine will fire forward to alter its trajectory and initiate descent. According to the mission plan, the lander will initially descend to an altitude of around 20 kilometers using inertia alone. It will then fire its main engine once more to decelerate to approximately 380 kilometers per hour. Upon reaching about three kilometers in altitude, the craft will enter its final landing phase, gradually reducing speed to around two kilometers per hour while adjusting its posture with both the main and auxiliary engines. Touchdown is scheduled for 4:17 AM in the Moon's northern region, near the so-called "Sea of Ice." The original landing time of 4:24 AM was revised on June 4. ispace previously attempted a lunar landing in 2023, but the mission ended in failure after the spacecraft lost altitude data and crashed from roughly five kilometers above the surface. For this second attempt, the company has significantly enhanced its altitude sensors and control systems to enable a more precise descent. Lunar module used in the HAKUTO-R lunar exploration program by ispace on April 26, 2023. (© JAPAN Forward by Hidemitsu Kaito) If successful, this will mark the first moon landing by a private company in Asia. Moreover, if ispace's in-house rover manages to traverse the lunar surface and collect regolith, it would become the first private firm in the world to achieve such a feat. Yoshitsugu Hitachi, lead developer for the second mission, voiced his determination at a May 30 press conference, stating: 'We've prepared thoroughly, drawing on the lessons from our first attempt. Our goal is complete success, from the landing itself to the surface exploration.' (Read the article in Japanese .) Author: Juichiro Ito, The Sankei Shimbun
National Post
6 hours ago
- National Post
Southwest Power Pool (SPP) Partners with Hitachi to Develop Advanced AI Solution for Critical Power Transmission Reliability and Flexibility Challenges
Article content End-to-end use of industrial AI and advanced computing infrastructure to help significantly speed up safe integration and use of additional energy sources supporting central U.S. power grids. Article content Initial partnership objectives are to reduce generator interconnection analysis times by 80% while facilitating more informed decision-making. Objective to be achieved via advanced AI solutions from Hitachi, powered by NVIDIA's accelerated computing platform. Integrated solution comprised of multiple Hitachi capabilities including an AI-based power simulation algorithm, Hitachi-iQ-accelerated calculations, augmented simulation modelling, predictive analytics, as well as design and engineering services. Wide-ranging impacts to address imminent U.S. energy infrastructure needs by increasing planning processes' speed and efficiency; enabling SPP to better resolve energy capacity shortages, increase grid reliability, and improve emergency response capabilities. Subsequent partnership objectives to address alternative energy integration challenges and power transmission constraints. Article content SANTA CLARA, Calif. & LITTLE ROCK, Ark. — Hitachi, Ltd. (TSE:6501, 'Hitachi') and Southwest Power Pool, Inc. (SPP) today announced a strategic partnership to solve critical and imminent problems slowing the modernization of U.S. energy infrastructure. The partnership will produce an integrated AI-based solution that accelerates generator interconnection (GI) by reducing study analysis times by 80% while also informing faster, higher-quality decision-making by GI customers. This will markedly improve SPP's ability to facilitate the addition of its 14-state region's generating capacity to keep pace with increasing demand for electricity. Article content U.S. energy demands are rising by 2 to 3 percent annually *1, driven by data center growth, expanding manufacturing, and electrification. Data centers alone are projected to consume up to 12 percent *2 of U.S. electricity by 2028, versus 4.4 percent in 2023. Such trends drive an alarming supply and demand gap as generating capacity margins in the SPP footprint could decline from 24 percent in 2020 to just 5 percent in 2029 unless an intervention occurs. Article content That intervention starts with end-to-end technical innovation, first at the point of generator interconnection. Currently, the U.S. generates 1.28 terawatts of power *3. More than twice that generated amount waits in a queue as unusable backlog caused by today's grid interconnect process. The long wait times are due to exhaustive, time-consuming analysis and simulation studies required to ensure that new energy source introductions don't compromise existing grid reliability, stability, or performance. Article content To address this gap, the three organizations will combine their industry and technical expertise. The partnership draws on multiple Hitachi competencies for a complete solution: Method's design services; GlobalLogic's software engineering services; Hitachi Energy's energy portfolio management asset modeling solutions; Hitachi R&D's AI-based energy grid algorithm; and Hitachi Vantara's integrated storage and compute platform Hitachi iQ, built on NVIDIA accelerated computing, networking, and AI software. Article content As the regional transmission organization (RTO) framing the project, SPP will guide the integration of these technical solutions and services, leveraging its deep expertise in energy grid optimization. As a reliability coordinator prioritizing operational and customer experience improvements, SPP's input will also ensure the project outcomes align with industry-wide requirements and regulations. 'Our nation's demand for electricity has risen sharply in recent years following a long period of slow growth. Our industry has struggled to keep up with this sudden and significant shift,' said SPP President and CEO Lanny Nickell. 'There are a lot of would-be power producers out there waiting to connect to the grid, but yesterday's systems and technology haven't been sufficient to enable us to bring incremental capacity online fast enough. It's time to fix that, and SPP is proud to work with Hitachi and NVIDIA, two AI industry leaders who have the means to help realize a vision of a better energy future for our nation.' Article content The integrated solution is an industrial AI system differentiated by its advanced proprietary AI algorithms and high performance enabled by Hitachi iQ's enterprise AI solution stack which sit at its core. Ultimately, dynamic AI-driven technologies will be applied to various study areas, such as: Article content The partnership with Hitachi and NVIDIA runs parallel to other improvements underway at SPP, including a from-the-ground-up reimagining of its transmission planning processes to align them with current and future industry needs. Together, these technological and process innovations are expected to set high-water marks in the electricity industry for generator interconnection, mid- and long-term planning, long-term forecast accuracy, analysis and deployment of additional grid-enhancing technologies, and more. Article content 'This initiative is about reimagining the electricity production and distribution process through the lens of modern AI technology,' said Frank Antonysamy, Chief Growth Officer, Hitachi Digital. 'Real-time data access is needed to create truly realistic scenarios caused by new generator introductions. The AI solution we're all developing will provide that data, among other advantages. SPP can then make significantly quicker, better-informed decisions that will increase overall ROI while better serving the nation's population with accessible power. We're proud to be a part of this important three-way collaboration addressing such a crucial problem.' Article content 'Interconnection process acceleration is critical to meet the unprecedented demand on our grid,' said Marc Spieler, Senior Managing Director of the Global Energy Industry at NVIDIA. 'Using advanced NVIDIA accelerated computing and AI, Hitachi and SPP are helping speed interconnection studies to bring essential infrastructure online faster.' Article content The project's phase one milestones are expected to be completed by winter 2025/26. They include initial systems acceleration, data management processes optimization, and the introduction of AI-augmented simulation modeling among other goals. Article content *1: *2: *3: About SPP Southwest Power Pool, Inc. ( is a regional transmission organization: a not-for-profit corporation mandated by the Federal Energy Regulatory Commission to ensure reliable supplies of power, adequate transmission infrastructure and competitive wholesale electricity prices on behalf of its members in 14 states. SPP ensures electric reliability across a region spanning parts of the central and western U.S., provides energy services on a contract basis to customers in both the Eastern and Western Interconnections, and is expanding its RTO and developing a day-ahead energy market in the west. The company's headquarters are in Little Rock, Arkansas. Article content About Hitachi, Ltd. Article content Article content Article content Contacts Article content Media Contacts Article content Article content Heather Ailara Article content Article content PR Manager Article content Article content Hitachi Digital (NA and EU) Article content Article content +1-973-567-6040 Article content Article content heather@ Article content Article content
National Post
6 hours ago
- National Post
ImmunoPrecise Announces AI-Driven Breakthrough in Universal Dengue Vaccine Discovery
Article content LENS ai ™ powered by HYFT® technology Identifies a single multi-factorial target conserved across all dengue serotypes. Article content AUSTIN, Texas — ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ:IPA) a leader in AI-driven biotherapeutics, announces discovery of a highly conserved epitope across all four dengue virus serotypes using its proprietary LENS ai ™ platform powered by their patented HYFT® technology. This discovery, made using several proprietary HYFT-based analyses, identifies a part of the virus (an epitope) that has remained unmutated across all four known virus serotypes, therefore potentially allowing an epitope-based vaccine to target and activate the immune system to eliminate the virus. This discovery marks a major milestone toward the development of a potential universal dengue vaccine and validates the Company's newly launched, HYFT pattern-patented AI-native vaccine discovery engine. Article content Dr. Jennifer Bath, ImmunoPrecise Antibodies CEO commented, 'This breakthrough highlights a new frontier in AI-driven biology—where discovery is rooted in the biology of a virus itself. By confirming that our sequence-derived patented HYFT patterns match structural signatures across all dengue serotypes, we're setting the stage for a universal vaccine design framework. Ultimately, this research validates a persistent target that may allow doctors to home in on a signal to eliminate the virus regardless of mutations that may have occurred. More importantly, the implications appear to stretch far beyond the dengue virus. This is a foundation that research indicates can now be applied to many other infectious diseases and potentially even certain types of cancer.' Article content Building on this success in dengue, IPA now intends to extend its AI-driven vaccine design platform to other high-impact infectious diseases, for example, HIV, Norovirus, and an improved RSV vaccine. Early-stage assessments are also underway to explore the platform's application in oncology for neoantigen vaccine development and tumor-specific epitope mapping. Article content This discovery underscores IPA's commitment to advancing drug discovery through innovative, human-relevant AI technologies that align with evolving industry standards. Using HYFT's patented ability to map biologically meaningful sub-sequence patterns across the entire biosphere, the Company's proprietary LENS ai platform identified a unique epitope shared across all four serotypes of the dengue virus—DENV-1, DENV-2, DENV-3, and DENV-4. These serotypes are distinct versions of the virus that circulate globally, and because infection with one does not protect against the others, identifying a common target is a critical step toward developing a broadly protective dengue vaccine. Unlike traditional trial-and-error methods, IPA's discovery was achieved entirely in silico, demonstrating the platform's power to translate complex biological data into actionable vaccine design. Article content Why Has a Universal Dengue Vaccine Been So Elusive? Article content Dengue is not just one virus—it's four distinct, rapidly-evolving serotypes. Immunity to one does not guarantee protection from the others, and prior infection can even make subsequent disease worse. For decades, vaccine researchers have struggled to find a viral component that is both exposed and truly conserved across all four types—a challenge compounded by the virus's rapid mutation and complex immune interactions. Traditional methods, whether experimental or computational, have repeatedly fallen short, unable to fully bridge the gap between sequence, structure, and function at a meaningful scale. Article content Confirmed Breakthrough: Sequence and Structural HYFT Match Across All Four Serotypes Article content IPA's discovery is a landmark moment in computational vaccinology. Using its proprietary LENSai™ platform powered by their patented HYFT® technology, the company has identified a strictly conserved epitope across all four dengue virus serotypes— a viral signature that remains unchanged despite mutations and serotype variation, and that can be targeted to trigger the immune system in efforts to eliminate the virus. This achievement marks a critical milestone in the quest for a universal dengue vaccine. Article content What sets this apart is the depth of validation: Article content Patented HYFT patterns, derived based on the conservation of sequence data. were independently confirmed to match corresponding structural HYFTs across all four dengue serotypes. This was made possible through LENS ai 's integration of over 20 million proprietary Structural HYFTs (S-HYFTs), enabling the platform to overlay three-dimensional conformations onto sequence-level, biology-native fingerprints. The validation demonstrates that LENS ai doesn't simply identify linear motifs—it can infer conformational and functional structures from sequence data alone, bypassing the need for time-consuming experimental techniques like crystallography or cryo-EM. Article content This milestone affirms the patented HYFT technology's unique ability to traverse the full biological hierarchy—from DNA/RNA sequence to molecular structure to therapeutic relevance. It signals that AI-native models, rooted in biology-first principles, can now deliver actionable insights previously achievable only through years of wet-lab research. Article content The end-to-end LENS ai platform integrates patented HYFT® universal fingerprints with deep learning, structural predictions, and literature-mined knowledge graphs to rapidly identify and refine candidate epitopes—without requiring lab-based inputs. The result: full immunogen design and in silico immunogenicity screening, dramatically reducing the time and cost of early-stage vaccine development and unlocking new opportunities to tackle even the most complex viral challenges. Article content About ImmunoPrecise Antibodies Ltd. Article content ImmunoPrecise Antibodies Ltd. is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the discovery and development of therapeutic antibodies and is known for solving complex industry challenges. IPA has several subsidiaries in North America and Europe including entities such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the 'IPA Family'). Article content Forward-Looking Statements Article content This press release contains forward-looking statements within the meaning of applicable United States and Canadian securities laws. Forward-looking statements are often identified by words such as 'expects,' 'intends,' 'plans,' 'anticipates,' 'believes,' or similar expressions, or statements that certain actions, events, or results 'may,' 'will,' 'could,' or 'might' occur or be achieved. These statements include, but are not limited to, those related to the anticipated benefits, scalability, adoption, and broader application of the LENS ai ™ and HYFT® platforms; the advancement and regulatory acceptance of AI-native drug discovery and vaccine development methods; the expansion of IPA's discovery engine to additional infectious disease and oncology targets; and the Company's ongoing ability to maintain scientific, regulatory, and commercial momentum. Article content Forward-looking statements are based on management's current expectations, assumptions, and projections about future events. Actual results may differ materially from those expressed or implied due to a variety of factors, many of which are beyond the Company's control. Such factors include, but are not limited to, scientific or technological developments, changes in regulatory requirements or acceptance, competitive or market dynamics, intellectual property protection and enforcement, integration or operational risks, and changes in economic or business conditions. Article content Forward-looking statements involve known and unknown risks, uncertainties, and other factors that could cause actual results, performance, or achievements to differ materially from those expressed or implied herein. Additional information regarding risks and uncertainties is included in the Company's Annual Report on Form 20-F, as amended, for the year ended April 30, 2024 (available on the Company's SEDAR+ profile at and EDGAR profile at Should any of these risks materialize, actual results could vary significantly from those currently anticipated. Article content Article content Article content Article content
